BACKGROUND: Nephropathia epidemica (NE) is the Scandinavian type of haemorrhagic fever with renal syndrome. Usually heavy transient proteinuria is present at the onset of the disease. METHODS: We investigated glomerular permeability in eight patients with acute NE and in eight healthy controls. Six patients were followed for 1 year. The glomerular filtration rate (GFR) was determined by inulin clearance and effective renal plasma flow (ERPF) by para-aminohippurate clearance. RESULTS: GFR and ERPF were significantly reduced in NE patients during the acute phase compared with those in controls (P<0.001 and P<0.001, respectively). The filtration fraction (FF) was thus high, 0.37. The fractional clearances of albumin, IgG, and IgG(4) were markedly increased. As a sign of tubular dysfunction, increased urinary excretion of alpha(1)-microglobulin was observed in all patients. After 1 year, the GFR of the patients no longer differed from that of the controls. ERPF was lower and FF higher than those in controls (P=0.014 and P=0.009, respectively). The fractional clearances of albumin, IgG, and IgG(4) remained increased. The high-molecular fractional dextran clearances in the patients were significantly increased compared with controls during the acute phase. Computed analysis of glomerular membrane-pore structure showed that the "shunt-flow" was increased in the patients during the acute phase compared with the controls. There was a positive correlation between the FF and the shunt (r=0.768, P=0.026). In addition, fractional clearances of albumin and IgG correlated significantly with the shunt (r=0.810, P=0.015 and r=0.762, P=0.028, respectively). CONCLUSIONS: Renal involvement in the acute phase of NE is characterized by a markedly decreased GFR and ERPF. Increased glomerular permeability is associated with impairment of both the size- and charge-selectivity properties of the glomerular filter.
BACKGROUND:Nephropathia epidemica (NE) is the Scandinavian type of haemorrhagic fever with renal syndrome. Usually heavy transient proteinuria is present at the onset of the disease. METHODS: We investigated glomerular permeability in eight patients with acute NE and in eight healthy controls. Six patients were followed for 1 year. The glomerular filtration rate (GFR) was determined by inulin clearance and effective renal plasma flow (ERPF) by para-aminohippurate clearance. RESULTS: GFR and ERPF were significantly reduced in NE patients during the acute phase compared with those in controls (P<0.001 and P<0.001, respectively). The filtration fraction (FF) was thus high, 0.37. The fractional clearances of albumin, IgG, and IgG(4) were markedly increased. As a sign of tubular dysfunction, increased urinary excretion of alpha(1)-microglobulin was observed in all patients. After 1 year, the GFR of the patients no longer differed from that of the controls. ERPF was lower and FF higher than those in controls (P=0.014 and P=0.009, respectively). The fractional clearances of albumin, IgG, and IgG(4) remained increased. The high-molecular fractional dextran clearances in the patients were significantly increased compared with controls during the acute phase. Computed analysis of glomerular membrane-pore structure showed that the "shunt-flow" was increased in the patients during the acute phase compared with the controls. There was a positive correlation between the FF and the shunt (r=0.768, P=0.026). In addition, fractional clearances of albumin and IgG correlated significantly with the shunt (r=0.810, P=0.015 and r=0.762, P=0.028, respectively). CONCLUSIONS: Renal involvement in the acute phase of NE is characterized by a markedly decreased GFR and ERPF. Increased glomerular permeability is associated with impairment of both the size- and charge-selectivity properties of the glomerular filter.
Authors: Antti Vaheri; Tomas Strandin; Jussi Hepojoki; Tarja Sironen; Heikki Henttonen; Satu Mäkelä; Jukka Mustonen Journal: Nat Rev Microbiol Date: 2013-08 Impact factor: 60.633
Authors: S F Khaiboullina; E V Martynova; Z L Khamidullina; E V Lapteva; I V Nikolaeva; V V Anokhin; V C Lombardi; A A Rizvanov Journal: Eur J Clin Microbiol Infect Dis Date: 2014-06-19 Impact factor: 3.267
Authors: Franz Maximilian Rasche; Boris Uhel; Detlev H Krüger; Wolfram Karges; David Czock; Walter Hampl; Frieder Keller; Helga Meisel; Lutz von Müller Journal: Emerg Infect Dis Date: 2004-08 Impact factor: 6.883
Authors: Joerg Latus; Matthias Schwab; Evelina Tacconelli; Friedrich-Michael Pieper; Daniel Wegener; Juergen Dippon; Simon Müller; David Zakim; Stephan Segerer; Daniel Kitterer; Martin Priwitzer; Barbara Mezger; Birgit Walter-Frank; Angela Corea; Albrecht Wiedenmann; Stefan Brockmann; Christoph Pöhlmann; M Dominik Alscher; Niko Braun Journal: Emerg Infect Dis Date: 2015-01 Impact factor: 6.883
Authors: Ekaterina V Martynova; Aygul H Valiullina; Oleg A Gusev; Yuriy N Davidyuk; Ekaterina E Garanina; Venera G Shakirova; Ilsiyar Khaertynova; Vladimir A Anokhin; Albert A Rizvanov; Svetlana F Khaiboullina Journal: J Immunol Res Date: 2016-12-05 Impact factor: 4.818
Authors: Paula S Mantula; Tuula K Outinen; Pia Jaatinen; Mari Hämäläinen; Heini Huhtala; Ilkka H Pörsti; Antti Vaheri; Jukka T Mustonen; Satu M Mäkelä Journal: PLoS One Date: 2018-12-05 Impact factor: 3.240
Authors: Priscilla F Kerkman; Andy Dernstedt; Lalitha Tadala; Eva Mittler; Mirjam Dannborg; Christopher Sundling; Kimia T Maleki; Johanna Tauriainen; Anne Tuiskunen-Bäck; Julia Wigren Byström; Pauline Ocaya; Therese Thunberg; Rohit K Jangra; Gleyder Román-Sosa; Pablo Guardado-Calvo; Felix A Rey; Jonas Klingström; Kartik Chandran; Andrea Puhar; Clas Ahlm; Mattias Ne Forsell Journal: Clin Transl Immunology Date: 2021-07-12